MAY 12th: International ME/CFS And FM Awareness Day

May 12th has been designated as International Awareness Day for Chronic Immunological and Neurological Diseases (CIND) since 1992. The CIND illnesses include Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), Fibromyalgia (FM), Gulf War Syndrome (GWS) and Multiple Chemical Sensitivity (MCS). May 12th was the birthday of Florence Nightingale, who was believed to have suffered from ME/CFS.

The aims on this day are to increase public awareness of the disease, educate the public, and lobby for more research into the causes and cure for ME/CFS and other Chronic Immunological and Neurological Diseases. Local, regional, and national organizations typically schedule events during the week of May 12, as well as the weeks just prior and after.

How to participate:

Wear Blue

Add a blue or purple ribbon to your FB page

If you have a Twitter account, post something about ME/CFS

Write a letter to the editor using the #MillionsMissing toolkit.

Here is Why Letter to the Editors are Important:
1. You can reach a large audience.
2. Great way to start a conversation around an issue that is important to you.
3. Helpful way to educate and spread awareness about ME.
4. Letters to the Editors are often monitored by elected officials.
5. Letters to the Editors are a great way to catch the attention of
journalists at the newspaper who may write a full article.
As part of the World ME Alliance WAMES is inviting you to use our new custom poster maker ahead of World ME Day on the 12th of May. Create your own poster alongside thousands of others this World ME Day. There are loads of templates for you to choose from See them HERE.

You can also participate in a number of events:

What can the world #LearnFromME? – This May 12th, the World ME Alliance is launching the first World ME Day, and we’re asking “what can the world #LearnFromME? “We want to use this World ME Day to share the realities of living with this disease, to reach out the health professionals and to bring organisations and individuals together, all calling for the world to #LearnFromME. Take part in our film! Send us a short video of yourself (15 seconds), describing something you have learnt from ME. We’ll join these together into one campaign video, to reach others and show the massive knowledge this community has, and the necessity of learning from ME.”

#MILLIONSMISSING GLOBAL VIRTUAL EVENT – Join ME community members and change makers for this event. The event will be an opportunity for our community to gather to experience the stories of those with ME, gain insight from doctors and researchers, connect with those living with Long COVID, and be galvanized to change the narrative and continue the fight for the #MillionsMissing. RSVP HERE>>

See the Millions Missing website for more ways to participate.

Solve ME Advocacy Month –  Advocacy Month is an opportunity to share the policy solutions vital to address the growing number of people suffering from ME/CFS and Long Covid. This year Solve ME is focusing on two main requests of the House and Senate chambers of Congress: Please co-sponsor the TREAT Long Covid Act (HR 7482), and Please co-sponsor the COVID-19 Long Haulers Act (HR 2754).  See Solve’s full roster of events HERE.

May Momentum launches on May 1st! Every Tuesday during May, OMF will be sharing new, exclusive video interviews with Directors of the OMF Collaborative Research Centers (CRC)s. Videos will be uploaded to YouTubetheir website, and shared via e-newsletter every Tuesday in May. These recordings will remain available to watch at your convenience.

Be sure to check the May 12 Facebook page for announcements of ongoing events.

Recursive Debility: Symptoms, Patient Activism, and the Incomplete Medicalization of ME/CFS

Abstract:

This article examines the contestation of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Lacking consistent diagnostic definitions, agreed-on biological indicators, or approved treatments, ME/CFS is an incompletely medicalized condition. It is defined by intractable and debilitating exhaustion after any form of exertion. Through an ethnographic exploration of an American ME/CFS patient activist group, I develop the concept of “recursive debility.” Symptoms form the very basis for disease activist groupings in the absence of biomarkers, but they also present a significant barrier to traditional forms of activism. Ironically, then, debilitation blocks the means through which debilitation might end. Patients contest systems of knowledge but always in bodies that experience exhaustion without end. This article presents a disability studies intervention in suggesting that the recursivity of debility demonstrates the profound interdependence of the bodily aspects of impairment and the sociopolitical aspects of disability.

Source: Rogers EL. Recursive Debility: Symptoms, Patient Activism, and the Incomplete Medicalization of ME/CFS. Med Anthropol Q. 2022 Mar 8. doi: 10.1111/maq.12701. Epub ahead of print. PMID: 35262958. https://pubmed.ncbi.nlm.nih.gov/35262958/

Sign for MECFS!

In Germany, there is virtually no medical care for ME/CFS patients and to date there is no government funding for biomedical scientific research into this devastating disease. With 50,000 signatories before the end of the deadline, we will even be granted a public hearing in the German Bundestag. This would be our best chance to finally draw attention to the issue of ME/CFS in German federal politics. Sign the petition! It will only take a few minutes and can be done online. Anyone can sign, worldwide! Read more here>>

ME/CFS: Exercise goals should be set by patients and not driven by treatment plan, says NICE

Letter:

Rapid Response:

Patient reports of harm from GET cannot be ignored

Dear Editor

Professor Trudie Chalder from King’s College Hospital states that:

“The NICE guidelines for CFS/ME are at odds with the research evidence. Researchers from different institutions in different countries have found graded exercise therapy and cognitive behaviour therapy to be effective for some patients with CFS.

Evidence has shown they reduce fatigue and improve functioning without harm, if delivered by trained therapists in specialist clinics. Being a clinician and researcher in this field, I can’t help but think clinicians will be confused by this message from a respected organisation.”

Having carefully reviewed all the very extensive evidence on efficacy and safety for graded exercise therapy (GET) from relevant clinical trials, medical experts and from people with ME/CFS, the NICE guideline committee concluded that in addition to there being no sound evidence for efficacy for GET there was also consistent patient evidence of harm, sometimes serious and persisting, occurring.

Read the rest of this letter HERE

Source: Charles Shepherd. BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2643 (Published 29 October 2021) BMJ 2021;375:n2643

Response to Adamson et al. (2020): ‘Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: Outcomes from a specialist clinic in the UK’

Abstract:

In a paper published in the Journal of the Royal Society of Medicine, Adamson et al. (2020) interpret data as showing that cognitive behavioural therapy leads to improvement in patients with chronic fatigue syndrome and chronic fatigue. Their research is undermined by several methodological limitations, including: (a) sampling ambiguity; (b) weak measurement; (c) survivor bias; (d) missing data and (e) lack of a control group. Unacknowledged sample attrition renders statements in the published Abstract misleading with regard to points of fact. That the paper was approved by peer reviewers and editors illustrates how non-rigorous editorial processes contribute to systematic publication bias.

Source: Hughes BM, Tuller D. Response to Adamson et al. (2020): ‘Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: Outcomes from a specialist clinic in the UK’. J Health Psychol. 2021 Apr 10:13591053211008203. doi: 10.1177/13591053211008203. Epub ahead of print. PMID: 33840241. https://pubmed.ncbi.nlm.nih.gov/33840241/

Long COVID Advocates Join Together To Form Alliance To Make Policy Recommendations, Secure Research Funding, And Transform Understanding Of Post-Viral Illnesses

Press Release:

LOS ANGELESFeb. 25, 2021 /PRNewswire/ — Today, leaders of 50 organizations and patient groups announced the formation of the Long COVID Alliance. The Alliance includes a network of patient-advocates, scientists, public health and disease experts, and drug developers who have joined together to leverage their collective knowledge and resources to educate policymakers and accelerate research that will address the challenges faced by ‘COVID long haulers’ and related post-viral illnesses.

Their goal is to transform the current understanding of Long COVID and related post-infectious illnesses such as:  myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), other forms of dysautonomia, Ehlers-Danlos syndrome (EDS), hypermobility spectrum disorder (HSD) and mast cell activation syndrome (MCAS), autoimmune diseases and other related illnesses.

“The Long COVID Alliance is a critical collaboration based on the current reality that doctors and researchers are reporting that millions of COVID-19 patients continue to experience chronic and often debilitating post-viral symptoms. This state of extended illness is presently labeled Long COVID,” said Oved Amitay, Solve M.E. President and Chief Executive Officer, one of the three Alliance founders. “Even though tests might reveal that no virus remains in the body, COVID-19 ‘long haulers’ continue to struggle, often alone. Our community brings past experiences that are relevant to the current crisis.”

In 2020, this same group came together to successfully call for urgent government investments for Long COVID, and $1.15 billion for long-term COVID-19 research at the National Institutes of Health shortly followed. The effort laid the foundation for the new Long COVID Alliance, which will prioritize:

  • Health equity and confronting systemic bias and racism in the Long COVID response;
  • Facilitating data harmonization (i.e., combine data from different sources and provide users with a comparable view of data from different studies);
  • Deploying financial resources from the NIH to create a public-private post-viral research infrastructure and translate research results into treatments and cures for millions;
  • Providing expert guidance and resources to media and policymakers;
  • Expanding public-private partnerships;
  • Leveraging existing post-viral disease knowledge and infrastructure;
  • Connecting policymakers with patients and scientists; and
  • Ensuring meaningful patient participation.

“So many patients have bonded together as the healthcare community has not understood why some patients are asymptomatic and others are suffering moderate to debilitating issues a year later,” said Hunter Howard, chairman of the Global Pandemic Coalition, a founder of the Alliance. “As one of the first infected in Texas, and a healthcare executive, I immediately noticed doctor friends did not understand my lingering symptoms or the novel coronavirus.  We started the Global Pandemic Coalition to bring together private companies to support the public sector pandemic initiatives.  If the vaccines continue to drive down mortalities, nothing may be more important now than coming together to drive understanding and fund research for the COVID survivors.”

To accompany the Long COVID Alliance’s launch, the initial partners from 2020 have drafted key recommendations and guidance for the National Institutes of Health (NIH), which can be found by visiting https://longcovidalliance.org/wp-content/uploads/2021/02/NIH-Long-COVID-Alliance-NIH-Recommendations-Letter-Final-with-signers.pdf

Current Long COVID Alliance partners include:

  • Action for M.E.
  • American Medical Women’s Association (AMWA)
  • Bateman Horne Center
  • Body Politic
  • Covid-19 Longhauler Advocacy Project
  • Dysautonomia International
  • ENIGMA COVID-19 Working Group
  • Florida Society of Neurology
  • HADASSAH
  • Health Rising
  • Healthy Women
  • Institute for Neuro-Immune Medicine (INIM)
  • Kantor Neurology, LLC
  • Long COVID Physio
  • Massachusetts ME/CFS & FM
  • #MEACTION
  • ME International
  • Medical Partnership 4 MS+
  • Minnesota ME/CFS Alliance
  • National Association for Nurse Practitioners in Women’s Health
  • National Health Council
  • National Organization for Women (NOW)
  • Nurse Practitioners in Women’s Health (NPWH)
  • Open Medicine Foundation
  • PandoraORG
  • PolyBio Research Foundation
  • Pulmonary Wellness Foundation
  • Sex and Gender Health Collaboration
  • Simmaron Research
  • Solve M.E.
  • The American Dysautonomia Institute (ADI)
  • The Mast Cell Disease Society, Inc.
  • The SHANE Foundation
  • Utah COVID-19 Long Hauler
  • Whittemore Peterson Institute
  • YOU + ME Registry (Solve M.E.)

“Many long haulers are now approaching a full year post-infection. We have lost jobs, lost significant quality of life, and lost pieces of who we once were. It’s been a long road with an uncertain future and we’ve finally found hope,” said Karyn Bishof, Founder of the COVID-19 Longhauler Advocacy Project and of the Long COVID Alliance. “With the help of our partners, we will ensure that Long haulers are not left out in the cold. The Long COVID Alliance will fight with us for awareness, answers, and ensuring that patient voices are included at every step of solving this ‘second wave’ Long COVID health crisis.”

To learn more, join the Long COVID Alliance, or become a signatory to the NIH letter, visit: www.longcovidalliance.org.

About Solve M.E.
The Solve ME/CFS Initiative (Solve M.E.) is the leading, national non-profit organization solely dedicated to solving ME/CFS. We are committed to making ME/CFS understood, diagnosable, and treatable. Solve M.E. is the largest U.S. provider of private competitive research funding exclusively for ME/CFS working to accelerate the discovery of safe and effective treatments; we strive for an aggressive expansion of funding for research that will lead to a cure, and seek to engage the entire ME/CFS community.

Media Inquiries Only 
Contact Emily Taylor
Director of Advocacy and Communications
714-296-1661
ETaylor@solvecfs.org

Chronic Disease Stakeholders Join SOLVE M.E. in Push for Federally Funded Research into Long COVID

Press Release: LOS ANGELES, Dec. 4, 2020 /PRNewswire/ — Twenty leading chronic disease stakeholders joined the Solve ME/CFS Initiative (Solve M.E.) in authoring a powerful letter urging Congress to fund millions of dollars in new National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) research into the post-viral health complications for long-term COVID-19 (Long COVID) survivors. To view a copy of the letter, click here.

With more than 13.9 million coronavirus infections in the U.S., the letter emphasizes the importance of research into chronic conditions known to be associated with viral triggers, such as: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Dysautonomia, Mast Cell Activation Syndrome (MCAS), and Postural Orthostatic Tachycardia Syndrome (POTS), among others. Authors of the letter include: Solve ME/CFS Initiative, National Health Council, National Organization for Women, #MEAction, Open Medicine Foundation, Dysautonomia International, The Mast Cell Disease Society, Body Politic, COVID-19 Longhauler Advocacy Project, Hadassah, American Medical Women’s Association, Nurse Practitioners in Women’s Health, HealthyWomen, Bateman-Horne Center, Institute for Neuro-immune Medicine, Pandora.Org, Sex and Gender Health Collaborative, Minnesota ME/CFS Alliance, The Shane Foundation, Massachusetts ME/CFS & FM Association, & The American Dysautonomia Institute.

Letter serves as a warning about the increasing number of COVID-19 patients experiencing post-viral complications.

“Preliminary evidence suggests that nearly five million Americans will experience Long COVID regardless of infection severity, which will likely result in a post-viral chronic fatigue crisis,” said Oved Amitay, CEO of Solve M.E. “Solve M.E. and our stakeholder allies call on Congress to act now to support new NIH and CDC funding for research into the health needs of this rapidly growing patient population.”

The letter cites warnings from leading public health officials — including Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases — about the estimated 3.2 million Americans that could be temporarily or permanently disabled by Long COVID symptoms. Indeed, studies show that 66 percent of patients with post-viral acute respiratory distress syndrome report experiencing severe fatigue after 12 months, consistent with Dr. Fauci’s analysis that Long COVID symptoms are “highly suggestive” of ME/CFS. These alarming statistics underscore the urgent need for funding, research, diagnostics, and treatment into Long COVID.

Chronic disease experts unanimously agree that in order to adequately address Long COVID complications, Congress must act immediately and appropriate the following funds:

$110 million for the establishment of Long COVID Collaborative Research Centers and Centers of Excellence;
$60 million toward expanding post-viral disease research;
$3.5 million for the development and issuance of medical guidance about Long COVID to medical providers and front-line health professionals; and
$300,000 toward convening experts and stakeholders to establish data harmonization.

“We strongly encourage these funds be allocated to the NIH and CDC by way of the congressional appropriations process or a future COVID-19 relief package so this critically important research can begin immediately,” said Amitay.

About Solve ME/CFS Initiative

Solve M.E. is the leading, national non-profit organization solely dedicated to solving ME/CFS. We are committed to making ME/CFS understood, diagnosable, and treatable. Solve M.E. works to accelerate the discovery of safe and effective treatments and strives for an aggressive expansion of funding for research that will lead to a cure.

To learn more, visit our website at www.solveCFS.org

Media Inquiries Only Contact
Emily Taylor
Director of Advocacy and Communications
714-296-1661
ETaylor@solvecfs.org

AMMES Stands Against Racism

The American ME and CFS Society wishes to make it clear that we unequivocally stand against racism in all its forms. Violence against black people is a long-standing blot upon our society, but it has now reached a crisis point. The recent murder of George Floyd has generated massive protests across the United States and around the world, but there are countless other black men and women whose senseless murders remain hidden from view. This assault against the black community must end. AMMES stands firmly behind Black Lives Matter and all other organizations which fight for justice and civil rights.

Racism is endemic in the United States. It is built into every facet of our society, from law enforcement to health care. In every manner, way, shape and form, black people have suffered the consequences of systemic racism. Violence against black people is not only manifested in assaults and murder, but in the enforced poverty imposed upon black communities and in a justice system that singles out black people for punishment, simply for the color of their skin.

People with ME/CFS may not be able to join the millions of people who are protesting in the streets, but we can express our support. If you have the money, you can donate to organizations such as the NAACP Legal Fund and the ACLU. You can contact your legislators at the state and national level and demand that police departments be held accountable. You can write letters to the editor, and post your support for Black Lives Matter on social media. There are additional actions you can take HERE.

Please join AMMES in supporting those who are seeking to eradicate racism.  Join us in saying ENOUGH!

 

Striking the balance with epistemic injustice in healthcare: the case of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

Abstract:

Miranda Fricker’s influential concept of epistemic injustice (Oxford University Press, Oxford, 2007) has recently seen application to many areas of interest, with an increasing body of healthcare research using the concept of epistemic injustice in order to develop both general frameworks and accounts of specific medical conditions and patient groups. This paper illuminates tensions that arise between taking steps to protect against committing epistemic injustice in healthcare, and taking steps to understand the complexity of one’s predicament and treat it accordingly. Work on epistemic injustice is therefore at risk of obfuscating legitimate and potentially fruitful inquiry.

This paper uses Chronic Fatigue Syndrome/Myalgic Encephalomyelitis as a case study, but I suggest that the key problems identified could apply to other cases within healthcare, such as those classed as Medically Unexplained Illnesses, Functional Neurological Disorders and Psychiatric Disorders. Future work on epistemic injustice in healthcare must recognise and attend to this tension to protect against unsatisfactory attempts to correct epistemic injustice.

Source: Byrne EA. Striking the balance with epistemic injustice in healthcare: the case of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Med Health Care Philos. 2020 Mar 13. doi: 10.1007/s11019-020-09945-4. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/32170570

Remembering The Forgotten: How AMMES Combats Isolation And Neglect

May is the month for acknowledging the Millions Missing – the millions of ME/CFS patients who, through the years, have suffered from poor medical care, insufficient research into the cause and mechanisms of the disease, and a paucity of clinical trials to discover effective treatment. May 12, Florence Nightingale’s birthday, is the day we recognize the toll ME/CFS takes on those who have the disease and on their families, who suffer alongside them.

Among the millions missing is a group that is often overlooked. These are the people for whom isolation does not simply mean the loss of friends and the inability to attend weddings, family gatherings, and social events. Isolation, for this group, means rejection, not just by society at large, but by the people closest to them. It means neglect on a scale that is incomprehensible to patients who have loving parents, siblings, and partners.

These “missing” people do not participate in advocacy actions – on any level. They are not to be found on forums, or social media. Their lives are lived silently, unseen by the ME/CFS community at large. These are the impoverished ill, people who have been abandoned by friends and family. Nobody will put their photos on a billboard, or write a news article about them, because these severely ill patients have not one living soul to defend them.

In May, the ME/CFS community remembers patients who have been neglected by the medical establishment as well as the government agencies responsible for their care. This month, the American ME and CFS Society (AMMES) remembers the patients who have been forgotten by everyone.

“Get me out of here!”

The first patient who came to AMMES for help was a black woman in her early thirties. She was pregnant at the time and needed help paying her security deposit. The AMMES financial crisis fund paid her landlord for the deposit and covered an outstanding water bill as well. Not too long afterwards, we received a frantic phone call from her: “Please, get me out of here!”

Our client had been the victim of abuse by a former boyfriend. In spite of a restraining order, her ex had broken into her house and assaulted her. She called her social worker, who phoned the police. When the police arrived they did not take a statement and, in spite of visible bruises on her face, they handcuffed our client and threw her into the back of a police car. They took her to a hospital, where she was placed in a psych ward and given antipsychotics. When I asked our client how it transpired that the police had taken her to a psych ward, she said it was at the request of her social worker. Our client had been diagnosed with CFS. She had no psychiatric diagnoses, and had never been evaluated by a psychiatrist.

Once we discovered what had happened, AMMES immediately wrote a letter to the hospital explaining that our client’s diagnosis was for a neuroimmune disease that had been well established as a physiological, not psychological, illness. We sent copies of the letter to her caregiver, who in turn gave them to the court, as well as to a team of social workers now on her case. A few days later our client was released.

This severely ill woman is black, poor, and female, and she had a diagnosis of CFS, which nobody in her circle of doctors and social workers understood. As a consequence, the full weight of societal prejudice fell on her. She is one of the forgotten.

 

“My family thinks I am making it up”

With the exception of the first applicant to the AMMES financial crisis fund, who had children, all of our applicants have lived alone. This does not necessarily mean that they do not have living parents or siblings. All of them have had at least some living family members, but their families have rejected them.

Those who have loving relatives find it hard to imagine how families can reject someone who is sick. Yet they do, mostly because they do not believe them. In the words of one applicant: “Over the last 11 years I have been treated like a lazy, worthless, liar.” Nobody believed that she was ill.

A number of applicants have reported similar experiences with family members who do not believe they are really sick. Some have had family members who have ostracized them or who – despite having comfortable incomes – refused to help, or even make a loan.

Other applicants have been treated with outright cruelty: “My brother told me to just kill myself, but before he did he told me that our mother’s condo that I am living in should be his not mine. So I really don’t have family that cares, or understands, or is safe for me to seek help from.”

In some cases, a state of homelessness has been caused by family rejection.

“My family, whose therapist said, “no one sleeps that much, unless they are a drug addict,” kicked me out last year. They have always chosen to have “willful ignorance”, so they did not feel any need to help. I don’t know which is worse anymore, the disease itself and how it hurts me or the hatred and selfish disregard for my life from other people.”

The truth is that no matter how much pain the illness causes, there is no pain that compares to being rejected by people who are supposed to love you. When doctors dismiss patients, or social services deny care, it is infuriating, frustrating, and humiliating. But when your own family does not care, or treats you worse than strangers do, it is heartbreaking.

“Your existence gives me hope in the future”

For the past year, AMMES has been stepping up to help severely ill patients with little to no income pay their bills. Most of our resources have gone to pay rent for patients on the verge of homelessness. We have also paid utility bills, medical copays, transportation costs, food expenses, medical bills and other necessities. We have even paid for a bed for one patient who had been sleeping on her couch. But the most valuable commodity we have to offer is love.

To say we love our applicants may sound like a Hallmark card, but when you demonstrate that you care, you are showing love. When you listen to patients who for years have suffered disappointment, rejection, and denial from all of the people surrounding them, you show them love. When you do your best to alleviate the isolation, humiliation, and hopelessness that these patients have had to endure, you show them love.

This May, AMMES would like you to show our clients some love as well. Our funds are depleted, which means we cannot take on new clients who are in danger of eviction. Nor can we take care of the clients we already have. We cannot bear to see our people evicted or going hungry because of lack of money. We can’t turn our backs on them.

AMMES’ May Fundraiser

Please DONATE to our cause! We launched our spring fundraiser on May 1. We need $15,000 to see us through until the fall, but any amount will keep us going.

Our fundraiser is HERE. Please spread the word everywhere you can!

You can also donate directly to AMMES HERE.

Our overhead is very low, so all donations will go directly into the financial crisis fund. AMMES is a 501(c)(3) nonprofit, so your donation is tax deductible.

Read more about what we do!

HOMELESS: How AMMES Is Keeping People With ME/CFS In Their Homes

Food, Clothing, And Shelter: Providing The Basics To People With ME/CFS

For my birthday, I would like…

It just so happens that my birthday falls on May 10th ! In addition to a pony, I would very much like to have some board members join AMMES. (A social worker would be almost as nice as a pony.) I am looking for people who are healthy, but who have a family member or friend with ME/CFS. You can find out more about Board positions HERE.

There is nothing more satisfying than the work we do! Join us!

Continue reading “Remembering The Forgotten: How AMMES Combats Isolation And Neglect”